Coston McIsaac & Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Hold
105
– – ﹤0.01% 711
2026
Q1
$5K Buy
+105
New +$4.9K ﹤0.01% 679
2025
Q1
– Sell
-173
Closed -$8K – 828
2024
Q4
$8K Hold
173
– – ﹤0.01% 529
2024
Q3
$9K Buy
+173
New +$9.34K ﹤0.01% 523

Other funds holding SNY

Coston McIsaac & Partners's SNY Position: Q2 2026 in Review

Coston McIsaac & Partners held its Sanofi (SNY) position steady in Q2 2026 at 105 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Coston McIsaac & Partners first reported a position in SNY in Q3 2024 and has held it in 4 quarters since. The position peaked at $9K in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Coston McIsaac & Partners held 105 shares of Sanofi worth $4K as of Q2 2026.
  • Coston McIsaac & Partners left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #711 holding.
  • Coston McIsaac & Partners first reported a position in Sanofi in Q3 2024 and has held it in 4 quarters since.
  • Coston McIsaac & Partners's Sanofi position peaked at $9K in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.